Sponsor Pipeline

TuHURA Biosciences, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
1
Phase 3
Active Trials by Phase
Phase 2/3
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT06947928 Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor… Advanced Or Metastatic Merkel Cell Carcinoma Recruiting
Phase 1
NCT06940440 IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell… Advanced Or Metastatic Merkel Cell Carcinoma Recruiting
Get alerts when TuHURA Biosciences, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free